Loading company…
US developer of percutaneous ventricular assist devices that support patients during high-risk heart procedures.
Founded in 2012 in the US, Supira Medical, Inc. develops percutaneous ventricular assist devices that give temporary mechanical support during high-risk coronary procedures and cardiogenic shock. Its low-profile, high-flow device assists the heart's natural pumping and includes real-time pump monitoring. In March 2025, the company raised USD 120.00 mn in Series E funding co-led by Novo Holdings and Qatar Investment Authority.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in